Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.62 - $0.85 $575,929 - $789,581
-928,919 Reduced 12.82%
6,315,113 $5.3 Million
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.35 $35,312 - $71,151
52,705 Added 0.73%
7,244,032 $5 Million
Q3 2023

Nov 14, 2023

BUY
$1.02 - $1.23 $87,383 - $105,374
85,670 Added 1.21%
7,191,327 $7.62 Million
Q2 2023

Aug 14, 2023

BUY
$1.04 - $1.4 $509,892 - $686,393
490,281 Added 7.41%
7,105,657 $7.96 Million
Q1 2023

May 15, 2023

BUY
$1.15 - $1.89 $290,593 - $477,584
252,690 Added 3.97%
6,615,376 $9.2 Million
Q4 2022

Feb 10, 2023

BUY
$0.96 - $1.6 $207,576 - $345,961
216,226 Added 3.52%
6,362,686 $7.19 Million
Q3 2022

Nov 14, 2022

BUY
$1.33 - $2.6 $817,116 - $1.6 Million
614,373 Added 11.11%
6,146,460 $10.1 Million
Q2 2022

Aug 12, 2022

SELL
$0.67 - $1.4 $105,951 - $221,391
-158,137 Reduced 2.78%
5,532,087 $7.25 Million
Q1 2022

May 13, 2022

BUY
$1.23 - $3.31 $642,051 - $1.73 Million
521,993 Added 10.1%
5,690,224 $7 Million
Q4 2021

Feb 14, 2022

BUY
$2.89 - $4.43 $301,236 - $461,756
104,234 Added 2.06%
5,168,231 $16.8 Million
Q3 2021

Nov 12, 2021

BUY
$3.36 - $4.62 $98,098 - $134,885
29,196 Added 0.58%
5,063,997 $21.1 Million
Q2 2021

Aug 13, 2021

BUY
$2.82 - $5.01 $14.2 Million - $25.2 Million
5,034,801 New
5,034,801 $21 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.